Literature DB >> 8339256

Glucocorticoid receptor expression during differentiation of human promyeloic leukemia cells.

M Zeiner1, U Gehring.   

Abstract

The human promyeloic leukemia cell line HL-60 can be triggered in culture to differentiate into several cell types of the myeloid lineage in response to a variety of chemical stimuli. We used this cell system in order to investigate the changes in glucocorticoid receptors which occur concomitantly with such cellular differentiations. Neutrophilic granulocytes obtained by the addition of dimethyl sulfoxide or retinoic acid to the culture medium showed only slight changes in cellular glucocorticoid receptor levels and receptor-specific mRNA as compared to undifferentiated control cells. Monocytic cells induced by incubation with dihydroxy-vitamin D3 had a moderate increase in receptor hormone-binding activity. However, differentiation toward macrophages by exposure to phorbol ester resulted in a 5- to 6- fold increase in both cellular hormone-binding capacity and immunochemically cross-reacting receptor protein. An even greater increase in glucocorticoid receptor-specific mRNA was observed. These data suggest that the receptor is regulated at the mRNA level and that de novo receptor synthesis occurs during macrophage differentiation, thus making these cells potentially more susceptible to glucocorticoid-induced effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8339256

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  Alpha and beta glucocorticoid receptor mRNA expression in skeletal muscle.

Authors:  S H Korn; E Koerts-de Lang; G E Engel; J W Arends; E F Wouters; F B Thunnissen
Journal:  J Muscle Res Cell Motil       Date:  1998-10       Impact factor: 2.698

2.  A protein that interacts with members of the nuclear hormone receptor family: identification and cDNA cloning.

Authors:  M Zeiner; U Gehring
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.